Cullinan Therapeutics, Inc. (CGEM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - | - |
| Cost of Goods Sold | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 77K | 76K | 77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -79K | 0 | 0 | 0 | 0 | 0 | 0 | -77K | -76K | -77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | 100% | - | - | - | - | - | - | - | - | - | - | -100% | - | - | - |
| Operating Expenses | 53.7M | 55.26M | 55.59M | 75.8M | 55M | 55.05M | 48.85M | 49.95M | 42.91M | 45.41M | 45.24M | 37.6M | 62.76M | 32.61M | 29.77M | -239.68M | 32.66M | 34.35M | 18.38M | 16.6M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.57M | 12.31M | 13.63M | 14.77M | 13.54M | 14.56M | 13.35M | 13.69M | 12.27M | 10.56M | 10.98M | 10.21M | 10.66M | 11.29M | 10.09M | 10.7M | 8.12M | 13.47M | 5.7M | 4.83M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 42.12M | 42.95M | 41.97M | 61.03M | 41.46M | 40.49M | 35.51M | 36.26M | 30.65M | 34.85M | 33.82M | 27.39M | 52.1M | 21.32M | 19.68M | 26.41M | 24.54M | 20.88M | 12.68M | 11.78M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 440K | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 |
| Operating Income | -53.7M | -55.26M | -55.59M | -75.8M | -55M | -55.05M | -48.85M | -50.03M | -42.99M | -45.48M | -45.24M | -37.6M | -62.76M | -32.61M | -29.77M | 239.68M | -32.66M | -34.35M | -18.38M | -16.6M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 2.36% | -0.38% | -13.8% | -51.51% | -27.93% | -21.02% | -7.98% | -33.03% | 31.5% | -39.49% | -52% | -115.69% | -92.17% | 5.06% | -61.99% | 1543.5% | -2480.25% | -17.74% | -59.8% | -17.58% |
| EBITDA | -53.62M | -55.18M | -55.52M | -75.72M | -54.92M | -54.97M | -48.78M | -49.95M | -42.91M | -45.41M | -45.16M | -37.52M | -62.68M | -32.55M | -29.76M | 239.69M | -32.64M | -34.34M | -18.36M | -16.59M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 2.37% | -0.38% | -13.81% | -51.59% | -27.98% | -21.06% | -8.01% | -33.11% | 31.54% | -39.51% | -51.77% | -115.66% | -92.02% | 5.2% | -62.06% | 1544.71% | -2453.57% | -17.76% | -59.89% | -17.62% |
| D&A (Non-Cash Add-back) | 79K | 79K | 79K | 77K | 76K | 77K | 76K | 77K | 76K | 77K | 80K | 81K | 72K | 59K | 9K | 12K | 13K | 12K | 13K | 13K |
| EBIT | -53.7M | -55.26M | -50.61M | -75.8M | -55M | -55.05M | -48.85M | -50.03M | -42.99M | -45.48M | -44.8M | -37.6M | -62.76M | -32.61M | -29.77M | -37.11M | -32.66M | -34.35M | -18.38M | -16.6M |
| Net Interest Income | 4.1M | 4.62M | 5.09M | 5.92M | 6.58M | 7.51M | 8.38M | 8.07M | 5.69M | 5.92M | 5.88M | 5.32M | 4.51M | 3.36M | 2.35M | 697K | 197K | 137K | 118K | 173K |
| Interest Income | 4.1M | 4.62M | 5.09M | 5.92M | 6.58M | 7.51M | 8.38M | 8.07M | 5.69M | 5.92M | 5.88M | 5.32M | 4.51M | 3.36M | 2.35M | 697K | 197K | 137K | 118K | 173K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.04M | 4.55M | 4.99M | 5.74M | 6.5M | 7.52M | 8.29M | 8M | 5.65M | 5.8M | 6.06M | 5.39M | 4.62M | 3.66M | 2.35M | 456K | 197K | 141K | 116K | 165K |
| Pretax Income | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.53M | -40.56M | -42.03M | -37.34M | -39.69M | -39.18M | -32.21M | -58.14M | -28.95M | -27.41M | 240.13M | -32.46M | -34.21M | -18.26M | -16.44M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 117K | 0 | 0 | 0 | -14.12M | 0 | 0 | 0 | -1.86M | -2.52M | 66.07M | -19.57M | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0.25% | 0% | 0% | 0% | 35.59% | 0% | 0% | 0% | 6.42% | 9.2% | 27.51% | 60.28% | 0% | 0% | 0% |
| Net Income | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.15M | -23.8M | -39.18M | -32.21M | -57.96M | -26.78M | -24.8M | 174.9M | -12.1M | -32.51M | -17.35M | -15.64M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -2.39% | -6.43% | -24.78% | -66.69% | -30.56% | -100.17% | -3.51% | -30.46% | 35.91% | 11.12% | -57.97% | -118.42% | -379.1% | 17.63% | -42.96% | 1218.56% | -17182.86% | -14.7% | -76% | -81.35% |
| Net Income (Continuing) | -49.66M | -50.71M | -50.61M | -70.06M | -48.5M | -47.65M | -40.56M | -42.03M | -37.34M | -25.56M | -39.18M | -32.21M | -58.14M | -27.09M | -24.89M | 174.06M | -12.89M | -34.21M | -18.26M | -16.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192K | 0 | 0 | 0 | 0 | 0 | 80K | 768K | 403K | 2.09M | 2.99M |
| EPS (Diluted) | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.77 | -0.27 | -0.74 | -0.40 | -0.36 |
| EPS Growth % | -2.44% | -6.17% | -22.86% | -56.58% | 4.65% | -44.64% | 23.91% | 6.17% | 39.44% | 5.08% | -70.37% | -121.49% | -425.93% | 20.27% | -35% | 1147.22% | - | -8.82% | -53.85% | 20% |
| EPS (Basic) | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 | -0.86 | -0.56 | -0.92 | -0.81 | -1.42 | -0.59 | -0.54 | 3.90 | -0.27 | -0.74 | -0.40 | -0.36 |
| Diluted Shares Outstanding | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 46.38M | 44.43M | 43.64M | 43.44M | 43.3M |
| Basic Shares Outstanding | 59.2M | 59.2M | 59.02M | 59.02M | 58.91M | 58.58M | 58.34M | 55.05M | 43.01M | 42.79M | 42.73M | 39.95M | 40.68M | 45.75M | 45.61M | 44.87M | 44.43M | 43.52M | 43.44M | 43.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |